𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Liver tumor ablation: Percutaneous and open approaches

✍ Scribed by Srikanth Padma; John B. Martinie; David A. Iannitti

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
271 KB
Volume
100
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The global incidence of liver cancer is greater than a million cases a year. Surgical resection where applicable is still the standard of care for these patients. Various liver‐directed regional therapies have been developed in an effort to treat the vast majority of unresectable liver tumors. This article reviews the principles behind various ablation therapies currently available for malignant liver tumors and their outcomes. J. Surg. Oncol. 2009;100:619–634. Β© 2009 Wiley‐Liss, Inc.

πŸ“œ SIMILAR VOLUMES

Percutaneous radiofrequency ablation of
Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection : The β€œtest-of-time” approach
✍ Juan Figueras; Laura LladΓ³ πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 50 KB

## Perceptions and Attitudes of Clinical Oncologists on Complementary and Alternative Medicine A Nationwide Survey in Japan I n their survey, Hyodo et al. 1 concluded that negative perceptions regarding complementary and alternative medicine (CAM) products persist among clinical oncologists in Jap

Percutaneous radiofrequency ablation of
Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection : The β€œtest-of-time” approach
✍ Tito Livraghi; Luigi Solbiati; Franca Meloni; Tiziana Ierace; S. Nahum Goldberg; πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 97 KB

## Abstract ## BACKGROUND Some surgeons have advocated delaying resection of liver metastases to allow additional metastases which may be present, but are undetected, to be identified. This β€œtest‐of‐time” approach can limit the number of resections performed on patients who ultimately will develop

Percutaneous radiofrequency ablation of
Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation
✍ David S. K. Lu; Nam C. Yu; Steven S. Raman; Charles Lassman; Myron J. Tong; Caro πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 187 KB πŸ‘ 1 views

Orthotopic liver transplantation (OLT) can be a definitive treatment for patients with hepatocellular carcinoma (HCC). Prolonged waiting times for cadaveric livers, however, may lead to dropout from the waiting list or worsened post-OLT prognosis as a result of interval tumor progression. Percutaneo